Bicycle Therapeutics PLC
NASDAQ:BCYC

Watchlist Manager
Bicycle Therapeutics PLC Logo
Bicycle Therapeutics PLC
NASDAQ:BCYC
Watchlist
Price: 23.14 USD -0.34% Market Closed
Market Cap: 1.6B USD
Have any thoughts about
Bicycle Therapeutics PLC?
Write Note

Bicycle Therapeutics PLC
Total Current Liabilities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Bicycle Therapeutics PLC
Total Current Liabilities Peer Comparison

Comparables:
CNTA
EXAI
AUTL
IMCR
GNS

Competitive Total Current Liabilities Analysis
Latest Figures & CAGR of Competitors

Company Total Current Liabilities CAGR 3Y CAGR 5Y CAGR 10Y
Bicycle Therapeutics PLC
NASDAQ:BCYC
Total Current Liabilities
$56.4m
CAGR 3-Years
23%
CAGR 5-Years
45%
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Total Current Liabilities
$39.4m
CAGR 3-Years
66%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Exscientia PLC
NASDAQ:EXAI
Total Current Liabilities
ÂŁ65.1m
CAGR 3-Years
48%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Total Current Liabilities
$44.7m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Total Current Liabilities
ÂŁ139m
CAGR 3-Years
36%
CAGR 5-Years
23%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Total Current Liabilities
ÂŁ150.6m
CAGR 3-Years
2%
CAGR 5-Years
8%
CAGR 10-Years
7%

See Also

What is Bicycle Therapeutics PLC's Total Current Liabilities?
Total Current Liabilities
56.4m USD

Based on the financial report for Sep 30, 2024, Bicycle Therapeutics PLC's Total Current Liabilities amounts to 56.4m USD.

What is Bicycle Therapeutics PLC's Total Current Liabilities growth rate?
Total Current Liabilities CAGR 5Y
45%

Over the last year, the Total Current Liabilities growth was -19%. The average annual Total Current Liabilities growth rates for Bicycle Therapeutics PLC have been 23% over the past three years , 45% over the past five years .

Back to Top